First Manhattan CO Vanda Pharmaceuticals Inc. Transaction History

First Manhattan CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$4.28 - $6.57 $4,280 - $6,570	-1,000 Reduced 90.91%	100 $0
Q2 2022 Aug 15, 2022	BUY	$9.31 - $11.84 $9,310 - $11,840	1,000 Added 1000.0%	1,100 $11,000
Q2 2019 Aug 16, 2019	SELL	$13.37 - $18.85 $5.07 Million - $7.15 Million	-379,304 Reduced 99.97%	100 $1,000
Q1 2019 Apr 12, 2019	SELL	$17.59 - $31.05 $9.85 Million - $17.4 Million	-559,970 Reduced 59.61%	379,404 $6.98 Million
Q4 2018 Jan 30, 2019	BUY	$18.97 - $31.47 $2.16 Million - $3.59 Million	113,999 Added 13.81%	939,374 $24.5 Million
Q3 2018 Oct 15, 2018	SELL	$18.25 - $23.0 $2.4 Million - $3.02 Million	-131,491 Reduced 13.74%	825,375 $18.9 Million
Q2 2018 Aug 01, 2018	BUY	$13.95 - $19.15 $13.3 Million - $18.3 Million	956,666 Added 478333.0%	956,866 $18.2 Million
Q3 2017 Oct 25, 2017	BUY	$15.4 - $18.85 $3,080 - $3,770	200	200 $3,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $274M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.